Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-17 8:24 pm Sale | 2026-06-15 | 13D | STABLECOIN DEVELOPMENT CORPORA SDEV | Framework Ventures IV L.P. | 32,690,366 45.900% | -24,720 (-0.08%) | Filing History |
| 2026-05-19 9:04 pm Purchase | 2026-05-17 | 13D | STABLECOIN DEVELOPMENT CORPORA SDEV | Framework Ventures IV L.P. | 32,715,086 46.400% | 10,562,391 (+47.68%) | Filing History |
| 2026-04-30 4:25 pm Purchase | 2026-04-29 | 13D | STABLECOIN DEVELOPMENT CORPORA SDEV | Framework Ventures IV L.P. | 22,152,695 44.500% | 10,791,479 (+94.99%) | Filing History |
| 2026-04-06 9:02 pm Purchase | 2026-03-31 | 13G | BETTER HOME & FIN HLDG CO COM BETR | Framework Ventures IV L.P. | 1,320,912 12.400% | 1,320,912 (New Position) | Filing History |
| 2026-01-21 8:12 pm Unchanged | 2026-01-16 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Framework Ventures IV L.P. | 11,361,216 45.000% | 0 (Unchanged) | Filing History |
| 2025-10-20 9:42 pm Purchase | 2025-10-16 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Framework Ventures IV L.P. | 11,361,216 45.100% | 11,128,393 (+4779.77%) | Filing History |
| 2025-10-15 8:28 pm Purchase | 2025-10-09 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Framework Ventures IV L.P. | 232,823 16.200% | 232,823 (New Position) | Filing History |